News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
683,224 Results
Type
Article (39229)
Company Profile (283)
Press Release (643712)
Section
Business (204567)
Career Advice (1992)
Deals (35461)
Drug Delivery (82)
Drug Development (80900)
Employer Resources (167)
FDA (16076)
Job Trends (14841)
News (345265)
Policy (32530)
Tag
Academia (2547)
Africa (715)
Alliances (49347)
Alzheimer's disease (1166)
Approvals (16005)
Arizona (178)
Artificial intelligence (86)
Asia (37080)
Australia (6052)
Bankruptcy (353)
Best Places to Work (11370)
Biosimilars (65)
Biotechnology (201)
Breast cancer (75)
C2C Services and Suppliers (79034)
California (2140)
Canada (1015)
Cancer (622)
Career advice (1661)
Cell therapy (152)
China (167)
Clinical research (63587)
Collaboration (196)
Colorado (88)
Compensation (112)
Connecticut (89)
COVID-19 (2517)
Cystic fibrosis (78)
Data (474)
Diabetes (99)
Diagnostics (6029)
Drug pricing (74)
Earnings (83830)
Employer resources (142)
Europe (79338)
Events (108599)
Executive appointments (184)
FDA (16381)
Florida (309)
Funding (188)
Gene therapy (105)
Georgia (68)
GLP-1 (530)
Government (4320)
Healthcare (18638)
Hotbed/Location (482625)
Illinois (277)
Indiana (155)
Infectious disease (2558)
Inflammatory bowel disease (96)
Interviews (306)
IPO (16251)
Job creations (3655)
Job search strategy (1425)
Kansas (95)
Layoffs (405)
Legal (7871)
Lung cancer (122)
Manufacturing (112)
Maryland (440)
Massachusetts (1744)
Medical device (13083)
Medtech (13088)
Mergers & acquisitions (19127)
Metabolic disorders (288)
Michigan (132)
Minnesota (226)
Neuroscience (1348)
New Jersey (652)
New York (667)
NextGen Class of 2024 (6517)
Non-profit (4469)
North Carolina (613)
Northern California (925)
Obesity (173)
Ohio (117)
Opinion (176)
Patents (80)
Pennsylvania (634)
People (56264)
Phase I (19720)
Phase II (28000)
Phase III (20919)
Pipeline (140)
Postmarket research (2551)
Preclinical (8371)
Radiopharmaceuticals (230)
Rare diseases (151)
Real estate (5930)
Regulatory (21359)
Research institute (2313)
Resumes & cover letters (348)
South America (1093)
Southern California (865)
Startups (3612)
Texas (278)
United States (9527)
Vaccines (495)
Washington State (267)
Weight loss (140)
Date
Today (27)
Last 7 days (656)
Last 30 days (2583)
Last 365 days (36701)
2024 (27583)
2023 (40177)
2022 (51288)
2021 (55836)
2020 (54157)
2019 (46644)
2018 (35124)
2017 (32224)
2016 (31629)
2015 (37706)
2014 (31454)
2013 (26500)
2012 (28770)
2011 (29426)
2010 (27525)
683,224 Results for "zivo bioscience inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
ZIVO Bioscience Announces Uplisting to OTCQB Market
Zivo Bioscience, Inc. announces it has uplisted the trading of shares of its common stock from the OTC ® Pink Market to the OTCQB ® Venture Market (OTCQB), effective as of the opening of trading on Friday, January 26, 2024.
January 29, 2024
·
4 min read
BioMidwest
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
Zivo Bioscience, Inc. announces additional findings from its 42-day coccidiosis challenge study that demonstrate the product’s positive impact on the cost of broiler production as an alternative to commonly-used antibiotics.
February 7, 2024
·
5 min read
Deals
ZIVO Bioscience Announces Reverse Stock Split
Zivo Bioscience, Inc. today announced that the Board of Directors of the Company approved a 1-for-6 reverse stock split (the “Reverse Stock Split”) of its shares of common stock, par value $0.001 (the “Common Stock”) effective at 5:00 p.m. ET on October 26, 2023.
October 26, 2023
·
2 min read
BioMidwest
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. announces positive efficacy results following its recent 42-day coccidiosis challenge study further demonstrating the effectiveness of its novel immune-modulating treatment for coccidiosis in broiler chickens.
January 23, 2024
·
5 min read
BioMidwest
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
Zivo Bioscience, Inc. announces that management will deliver a company presentation and will hold investor meetings at the 8th Annual Dawson James Small Cap Growth Conference being held Thursday, October 12, 2023.
October 3, 2023
·
3 min read
BioMidwest
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. announces the initiation of a 42-day study to further validate the efficacy of its novel immune-modulating treatment for coccidiosis in broiler chickens.
October 30, 2023
·
5 min read
BioMidwest
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
Zivo Bioscience, Inc. announces positive results from a month-long coccidiosis trial in broiler chickens that was conducted by an independent veterinary research provider.
September 19, 2023
·
5 min read
BioMidwest
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
Zivo Bioscience, Inc. announces the commercialization of its proprietary algal biomass as a food or food ingredient.
July 26, 2023
·
6 min read
BioMidwest
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
Zivo Bioscience, Inc. provided an update on the commercialization of Zivolife, its proprietary algal biomass as a food or food ingredient.
August 16, 2023
·
5 min read
BioMidwest
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
Zivo Bioscience, Inc. announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 1,498,130 shares of common stock in a registered direct offering priced at-the-market under Nasdaq rules.
June 30, 2023
·
4 min read
1 of 68,323
Next
